Clinical Trial Update: Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of oxaliplatin in patients with recurrent or refractory cervical cancer has completed. The update documents the study’s status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED